Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Cronos Group

Tilray Brands

Legal barriers are falling, and the North American market is set to be in flux.

3 Big Changes Could Be Coming for Cannabis Stocks Before 2024

Canopy Growth investors shouldn't simply rely on hopes for legalization in the U.S. market.

3 Glaring Red Flags Canopy Growth Investors Can't Afford to Ignore

Agenus

Amyris

Ginkgo Bioworks Holdings

Globalstar

Nordic American Tankers

Qurate Retail Inc

Transocean

SoFi Technologies

Viking Therapeutics

Penny stocks to watch with unusual options activity this week. The post 10 Top Penny Stocks With Unusual Options Activity, Time To Buy?

10 Top Penny Stocks With Unusual Options Activity, Time To Buy?

2 Canadian Marijuana Stocks To Know About In 2023 The post 2 Canadian Marijuana Stocks To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks To Watch This Week

Penny stocks to watch with unusual options activity this week. The post 7 Top Penny Stocks With Unusual Options Activity, Time To Buy?

7 Top Penny Stocks With Unusual Options Activity, Time To Buy?

It's planning to shift the center of gravity of its business from Canada to the U.S.

Canopy Growth Just Made a Smart Move. Here's How to Profit

Penny stocks with unusual options activity; are they a buy or should you avoid them entirely? The post 3 Top Penny Stocks With Unusual Options Activity, Time To Buy?

3 Top Penny Stocks With Unusual Options Activity, Time To Buy?

Investors in these companies should be careful what they wish for.

Why Marijuana Legalization Could Be Bad News for Canopy Growth and Tilray Brands

What you need to know about buying marijuana penny stocks right now The post Marijuana Penny Stocks Buying Guide: Do's and Dont's  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Marijuana Penny Stocks Buying Guide: Do's and Dont's

Marijuana legalization is coming, and marijuana investors like the sound of that.

Why Canopy Growth, Tilray, and Aurora Cannabis Stocks Glowed Green on Tuesday

Village Farms International

Are Canadian Pot Stocks A Buy Before US Federal Reform? The post Canadian Marijuana Stocks For Mid November Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks For Mid November Watchlist

Buying marijuana penny stocks? 3 reasons to do so The post Are Marijuana Penny Stocks Worth Buying?

Are Marijuana Penny Stocks Worth Buying? 3 Reasons

Aurora Cannabis just reported a 28% decline in consumer marijuana sales -- and this is good news?

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Glowed Green on Friday

These beaten-down marijuana stocks are heating up today.

Why Shares of Aurora Cannabis, Canopy Growth, and Tilray Are Glowing Green Today

Canopy Growth may be known for being one of Canada's largest cannabis companies, but its biggest hit of the current earnings season has a different connection with grass.

Canopy Growth, Tilray eye growth from non-cannabis drinks

Can Canopy Growth escape the fate of other money-losing marijuana stocks?

Why Canopy Growth Moved Higher Today, but Other Marijuana Stocks Fell

Roundhill Cannabis ETF

Canopy Growth Corporation (NASDAQ:CGC ) Q2 2023 Earnings Conference Call November 9, 2022 10:00 AM ET Company Participants Tyler Burns - Director of Investor Relations David Klein - Chief Executive Officer Judy Hong - Chief Financial Officer Conference Call Participants Victor Ma - Cowen & Company Chris Carey - Wells Fargo Tamy Chen - BMO Capital Markets Pablo Zuanic - Cantor Fitzgerald Andrew Carter - Stifel John Zamparo - CIBC Nadine Sarwat - Bernstein Doug Miehm - RBC Capital Markets Bill Kirk - MKM Partners Michael Lavery - Piper Sandler Operator Good morning. My name is Michele.

Canopy Growth Corporation (CGC) Q2 2023 Earnings Call Transcript

The company's strategy for the U.S. market could come with significant consequences.

Could Canopy Growth Get Delisted From Nasdaq?

Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -55.56% and 0.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth Corporation (CGC) Reports Q2 Loss, Tops Revenue Estimates

Canopy Growth Corp. WEED, -2.75% CGC, -0.31% shares rose 2.5% in premarket trades after the cannabis company beat its second-quarter revenue target. Canopy Growth's second-quarter loss widened to C$231.9 million, or 47 cents a share, from C$11.06 million, or 3 cents a share, in the year-ago quarter.

Canopy Growth loss widens but revenue beats estimate

SMITHS FALLS, ON , Nov. 9, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announces its financial results for the second quarter ended September 30, 2022. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Canopy Growth Corporation Reports Second Quarter Fiscal Year 2023 Financial Results

D.R. Horton

Hecla Mining

The three major U.S. equity indexes closed higher Friday. The Dow Jones industrials ended the day up 1.26%, the S&P 500 closed 1.36% higher and the Nasdaq saw a gain of 1.28%.

Earnings Previews: Canopy Growth, DR Horton, Hecla Mining

Canopy Growth is going to execute on its pending deals through a holding company.

Does the Canopy USA Launch Make Canopy Growth a Buy?

Couche-Tard has been eyeing the cannabis industry for years.

Want to Invest in Cannabis With Minimized Risk? Buy This Growth Stock.

Bionano Genomics

FuelCell Energy

Hall of Fame Resort & Entertainment

Meta Materials

B2Gold

It may seem a little crazy to talk about finding cheap penny stocks to buy at this time. The economy is cooling, and even blue-chip stocks are struggling to gain traction.

News for Canopy Growth Stock (CGC)